Table 1.
Characteristics | Current FDA-approved vaccines |
New vaccines |
||
---|---|---|---|---|
IIV | LAIV | RIV | CPB/CB | |
Safety | ++ | + | ++ | ++ |
| ||||
Immunogenicity | + | ++ | + | ++ |
| ||||
Humoral response | Yes | Yes | Yes | Yes |
| ||||
Cellular response | Weak | Yes | Weak | Yes |
| ||||
Manufacturing method |
Egg-based production | Tissue culture (insect) | Tissue culture (mammalian) |
CB: Codon bias; CPB: Codon pair bias; IIV: Inactivated influenza vaccine; LAIV: Live attenuated influenza vaccine; RIV: Recombinant influenza vaccine.